Special Issue "Bioactive Metabolites from Marine-Derived Penicillium or Aspergillus Species"
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Pharmacology".
Deadline for manuscript submissions: 15 February 2024 | Viewed by 84
Special Issue Editor
Dr. Zhongbin Cheng
Interests: natural product chemistry; bioactivity; marine; fungi; penicillium; aspergillus
Special Issue Information
Dear Colleagues,
Filamentous fungal strains, particularly species belonging to Penicillium or Aspergillus, are a vital source of structurally diverse molecules with pharmaceutical potential. Since the miraculous medicine penicillin G was discovered from P. notatum in 1928, the discovery of potent cholesterol-lowering agents, including compactin from P. citrinum, lovastatin from P. compactum and A. terreus, and the immunosuppressant mycophenolic acid from P. brevicompactum, has proven that these two genera are potential sources of bioactive compounds.
In recent decades, with the development of separation and structural identification techniques, improvements in our ocean-going and deep-diving capabilities, as well as the invention of advanced sampling and cultivation equipment, numerous marine-derived Penicillium or Aspergillus strains have been discovered; these have provided us human beings with many molecules possessing fascinating biological and pharmacological properties.
In this Special Issue, research papers and pertinent reviews focusing on topics such as the isolation and structural elucidation, chemical synthesis, biosynthesis, and pharmaceutical mechanisms of bioactive metabolites discovered from marine-derived Penicillium or Aspergillus species are welcome.
Dr. Zhongbin Cheng
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine-derived fungi
- penicillium
- aspergillus
- bioactivity
- isolation and structural elucidation
- chemical synthesis
- biosynthesis
- pharmaceutical mechanisms
